Trulicity ® (dulaglutide)

This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information.For current prescribing information for all Lilly products, including Summaries of Product Characteristics, Patient Information Leaflets and Instructions for Use, please visit: (England, Scotland, Wales) or (Northern Ireland).

Trulicity® (dulaglutide): Use with COVID-19 Vaccines

The use of vaccines against SARS-CoV-2 in patients treated with dulaglutide has not been studied.

Detailed Information

COVID-19 is an infectious respiratory disease caused by SARS-CoV-2, previously referred to as "2019 novel coronavirus."1

The use of a SARS-CoV-2 vaccine in patients treated with dulaglutide has not been studied by Lilly.

Decisions regarding the use of any vaccination, including SARS-CoV-2 vaccines, in patients treated with dulaglutide should be made at the discretion of the prescribing physician using their best clinical judgment, and must be made by the clinician after careful consideration of risk factors of the patient as well as the risks and benefits of vaccination. Consultation with an infectious disease expert may be helpful in high-risk or emergency situations such as the current COVID-19 pandemic.

Possible impact of vaccination on blood glucose concentration

The International Diabetes Federation IDF states that after any vaccination the blood glucose levels might rise for a few days.2

Further resources on COVID-19 Vaccines and Diabetes

For information on COVID-19 vaccines and diabetes, please refer to

For current information on COVID-19 and COVID-19 vaccines in gereral, please refer to


1. Naming the coronavirus disease (COVID-19) and the virus that causes it. World Health Organization. Accessed March 17, 2020.

2. International Diabetes Federation Europe. Diabetes & Coronavirus Vaccination. Accessed April 29, 2021

3. Coronavirus disease (COVID-19) outbreak. European web page of the World Health Organization. Accessed March 20, 2020.

4. COVID-19. European Centre for Disease Prevention and Control. Accessed March 20, 2020.


COVID-19 = coronavirus disease 2019

ECDC = European Centre for Disease Prevention and Control

EU WHO = World Health Organization (European regional office)

IDF = International Diabetes Federation

Lilly = Eli Lilly and Company

SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2

Date of Last Review: 12 January 2021

Contact Lilly

Call or Email us

If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at

Available Mon - Fri, 10am - 4pm, excluding Bank Holidays

Or you can

Chat with Us

Click to Chat is Offline

If you have a question, you can chat online with a Lilly Medical Information professional.

Submit a request